Invention Grant
- Patent Title: Oral pharmaceutical solutions containing telbivudine
- Patent Title (中): 含有替比夫定的口服药物溶液
-
Application No.: US12667975Application Date: 2008-07-10
-
Publication No.: US08445457B2Publication Date: 2013-05-21
- Inventor: Nabila Sekkat
- Applicant: Nabila Sekkat
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent David R. Kurlandsky
- Priority: EP07112381 20070712
- International Application: PCT/EP2008/059016 WO 20080710
- International Announcement: WO2009/007426 WO 20090115
- Main IPC: A01N43/04
- IPC: A01N43/04 ; A61K31/70
Abstract:
A pharmaceutical solution suitable for oral administration comprising β-L-thymidine/2′-deoxy-L-thymidine (telbivudine), a pharmaceutically suitable solvent system, one or more taste-enhancing/masking agents, a preservative system, and a buffer system suitable to allow both drug stability and preservation.
Public/Granted literature
- US20100197629A1 ORAL PHARMACEUTICAL SOLUTIONS CONTAINING TELBIVUDINE Public/Granted day:2010-08-05
Information query
IPC分类:
